Suchergebnisse - "Local (mesh)"

Survivorship in advanced ovarian cancer: a prognostic model for overall survival and risk of recurrence

Autoren: Shachar, Eliya Raz, Yael Rotkop, Gilat et al.

Quelle: The Oncologist. 30(9)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Cancer (rcdc), Clinical Research (rcdc), Women's Health (rcdc), Ovarian Cancer (rcdc), Rare Diseases (rcdc), 4.2 Evaluation of markers and technologies (hrcs-rac), 2.4 Surveillance and distribution (hrcs-rac), Cancer (hrcs-hc), 3 Good Health and Well Being (sdg), Humans (mesh), Female (mesh), Middle Aged (mesh), Prognosis (mesh), Retrospective Studies (mesh), Ovarian Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Aged (mesh), Adult (mesh), Carcinoma, Ovarian Epithelial (mesh), Cancer Survivors (mesh), Survival Rate (mesh), ovarian cancer, long-term survivors, prognostic model, optimal debulking, BRCA, overall survival, risk of recurrence, platinum sensitivity, homologous recombination deficiency, Humans (mesh), Ovarian Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Prognosis (mesh), Survival Rate (mesh), Retrospective Studies (mesh), Adult (mesh), Aged (mesh), Middle Aged (mesh), Female (mesh), Cancer Survivors (mesh), Carcinoma, Ovarian Epithelial (mesh), BRCA, homologous recombination deficiency, long-term survivors, optimal debulking, ovarian cancer, overall survival, platinum sensitivity, prognostic model, risk of recurrence, Humans (mesh), Female (mesh), Middle Aged (mesh), Prognosis (mesh), Retrospective Studies (mesh), Ovarian Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Aged (mesh), Adult (mesh), Carcinoma, Ovarian Epithelial (mesh), Cancer Survivors (mesh), Survival Rate (mesh), 1112 Oncology and Carcinogenesis (for), Oncology & Carcinogenesis (science-metrix), 3211 Oncology and carcinogenesis (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/3nk6r4hm
https://escholarship.org/content/qt3nk6r4hm/qt3nk6r4hm.pdf

Impact of postoperative fluorodeoxyglucose positron emission tomography/computed tomography on adjuvant head and neck cancer treatment

Autoren: Courtney, P Travis Casillas, Jesus E Juarez Liu, Eulanca Y et al.

Quelle: JNCI Cancer Spectrum. 9(4)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Clinical Trials and Supportive Activities (rcdc), Cancer (rcdc), Rare Diseases (rcdc), Dental/Oral and Craniofacial Disease (rcdc), Clinical Research (rcdc), Biomedical Imaging (rcdc), Bioengineering (rcdc), Cancer (hrcs-hc), Humans (mesh), Positron Emission Tomography Computed Tomography (mesh), Retrospective Studies (mesh), Fluorodeoxyglucose F18 (mesh), Female (mesh), Male (mesh), Head and Neck Neoplasms (mesh), Middle Aged (mesh), Aged (mesh), Neoplasm Recurrence, Local (mesh), Radiopharmaceuticals (mesh), Neoplasm, Residual (mesh), Adult (mesh), Postoperative Period (mesh), Aged, 80 and over (mesh), Humans (mesh), Head and Neck Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Neoplasm, Residual (mesh), Fluorodeoxyglucose F18 (mesh), Radiopharmaceuticals (mesh), Postoperative Period (mesh), Retrospective Studies (mesh), Adult (mesh), Aged (mesh), Aged, 80 and over (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), Positron Emission Tomography Computed Tomography (mesh), Humans (mesh), Positron Emission Tomography Computed Tomography (mesh), Retrospective Studies (mesh), Fluorodeoxyglucose F18 (mesh), Female (mesh), Male (mesh), Head and Neck Neoplasms (mesh), Middle Aged (mesh), Aged (mesh), Neoplasm Recurrence, Local (mesh), Radiopharmaceuticals (mesh), Neoplasm, Residual (mesh), Adult (mesh), Postoperative Period (mesh), Aged, 80 and over (mesh), 3211 Oncology and carcinogenesis (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/0kb0c018
https://escholarship.org/content/qt0kb0c018/qt0kb0c018.pdf

Combination Treatment of Rituximab and Therapeutic Vaccines Affords Superior Tumor Suppression and Relapse Prevention for Non‐Hodgkin Lymphoma

Autoren: Qi, Tong Guo, Jimin Cao, Zheng et al.

Quelle: Advanced Materials. 37(26)

Schlagwörter: 40 Engineering (for-2020), 34 Chemical Sciences (for-2020), 51 Physical Sciences (for-2020), Lymphatic Research (rcdc), Hematology (rcdc), Immunotherapy (rcdc), Cancer (rcdc), Orphan Drug (rcdc), Lymphoma (rcdc), Vaccine Related (rcdc), Immunization (rcdc), Biotechnology (rcdc), Rare Diseases (rcdc), Prevention (rcdc), 5.1 Pharmaceuticals (hrcs-rac), 6.1 Pharmaceuticals (hrcs-rac), Cancer (hrcs-hc), 3 Good Health and Well Being (sdg), Animals (mesh), Rituximab (mesh), Humans (mesh), Mice (mesh), Lymphoma, Non-Hodgkin (mesh), Cancer Vaccines (mesh), Cell Line, Tumor (mesh), Neoplasm Recurrence, Local (mesh), BLT humanized mouse model, immunotherapy, non-Hodgkin lymphoma, synergy therapy, therapeutic cancer vaccines, Cell Line, Tumor (mesh), Animals (mesh), Humans (mesh), Mice (mesh), Lymphoma, Non-Hodgkin (mesh), Neoplasm Recurrence, Local (mesh), Cancer Vaccines (mesh), Rituximab (mesh), BLT humanized mouse model, immunotherapy, non‐Hodgkin lymphoma, synergy therapy, therapeutic cancer vaccines, Animals (mesh), Rituximab (mesh), Humans (mesh), Mice (mesh), Lymphoma, Non-Hodgkin (mesh), Cancer Vaccines (mesh), Cell Line, Tumor (mesh), Neoplasm Recurrence, Local (mesh), 02 Physical Sciences (for), 03 Chemical Sciences (for), 09 Engineering (for), Nanoscience & Nanotechnology (science-metrix), 34 Chemical sciences (for-2020), 40 Engineering (for-2020), 51 Physical sciences (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/8cc8z0xw
https://escholarship.org/content/qt8cc8z0xw/qt8cc8z0xw.pdf

Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses

Autoren: Lucas, Calixto-Hope G Al-Adli, Nadeem N Young, Jacob S et al.

Quelle: Neuro-Oncology. 27(1)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Genetics (rcdc), Orphan Drug (rcdc), Rare Diseases (rcdc), Neurosciences (rcdc), Brain Disorders (rcdc), Cancer (rcdc), Cancer Genomics (rcdc), Brain Cancer (rcdc), Human Genome (rcdc), 2.1 Biological and endogenous factors (hrcs-rac), Cancer (hrcs-hc), Humans (mesh), Glioblastoma (mesh), Brain Neoplasms (mesh), Isocitrate Dehydrogenase (mesh), Female (mesh), Male (mesh), Middle Aged (mesh), DNA Methylation (mesh), Mutation (mesh), Prognosis (mesh), Adult (mesh), Phenotype (mesh), Aged (mesh), Neoplasm Recurrence, Local (mesh), Biomarkers, Tumor (mesh), Survival Rate (mesh), Follow-Up Studies (mesh), Promoter Regions, Genetic (mesh), Epigenesis, Genetic (mesh), DNA methylation, glioblastoma, gliosarcoma, molecular neuropathology, temozolomide-induced hypermutation, Humans (mesh), Glioblastoma (mesh), Brain Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Isocitrate Dehydrogenase (mesh), Prognosis (mesh), Survival Rate (mesh), Follow-Up Studies (mesh), DNA Methylation (mesh), Epigenesis, Genetic (mesh), Phenotype (mesh), Mutation (mesh), Adult (mesh), Aged (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), Promoter Regions, Genetic (mesh), Biomarkers, Tumor (mesh), DNA methylation, glioblastoma, gliosarcoma, molecular neuropathology, temozolomide-induced hypermutation, Humans (mesh), Glioblastoma (mesh), Brain Neoplasms (mesh), Isocitrate Dehydrogenase (mesh), Female (mesh), Male (mesh), Middle Aged (mesh), DNA Methylation (mesh), Mutation (mesh), Prognosis (mesh), Adult (mesh), Phenotype (mesh), Aged (mesh), Neoplasm Recurrence, Local (mesh), Biomarkers, Tumor (mesh), Survival Rate (mesh), Follow-Up Studies (mesh), Promoter Regions, Genetic (mesh), Epigenesis, Genetic (mesh), 1109 Neurosciences (for), 1112 Oncology and Carcinogenesis (for), Oncology & Carcinogenesis (science-metrix), 3211 Oncology and carcinogenesis (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/0gg6p5rb
https://escholarship.org/content/qt0gg6p5rb/qt0gg6p5rb.pdf

PSMA-PET/CT Findings in Patients With High-Risk Biochemically Recurrent Prostate Cancer With No Metastatic Disease by Conventional Imaging

Autoren: Holzgreve, Adrien Armstrong, Wesley R Clark, Kevyn J et al.

Quelle: JAMA Network Open. 8(1)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Aging (rcdc), Health Disparities (rcdc), Biomedical Imaging (rcdc), Prostate Cancer (rcdc), Clinical Research (rcdc), Clinical Trials and Supportive Activities (rcdc), Urologic Diseases (rcdc), Cancer (rcdc), 4.2 Evaluation of markers and technologies (hrcs-rac), Cancer (hrcs-hc), 3 Good Health and Well Being (sdg), Humans (mesh), Male (mesh), Positron Emission Tomography Computed Tomography (mesh), Prostatic Neoplasms (mesh), Aged (mesh), Middle Aged (mesh), Retrospective Studies (mesh), Neoplasm Recurrence, Local (mesh), Cross-Sectional Studies (mesh), Prostate-Specific Antigen (mesh), Antigens, Surface (mesh), Nitriles (mesh), Phenylthiohydantoin (mesh), Neoplasm Staging (mesh), Leuprolide (mesh), Glutamate Carboxypeptidase II (mesh), Benzamides (mesh), Humans (mesh), Prostatic Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Benzamides (mesh), Nitriles (mesh), Phenylthiohydantoin (mesh), Leuprolide (mesh), Prostate-Specific Antigen (mesh), Glutamate Carboxypeptidase II (mesh), Antigens, Surface (mesh), Neoplasm Staging (mesh), Retrospective Studies (mesh), Cross-Sectional Studies (mesh), Aged (mesh), Middle Aged (mesh), Male (mesh), Positron Emission Tomography Computed Tomography (mesh), Humans (mesh), Male (mesh), Positron Emission Tomography Computed Tomography (mesh), Prostatic Neoplasms (mesh), Aged (mesh), Middle Aged (mesh), Retrospective Studies (mesh), Neoplasm Recurrence, Local (mesh), Cross-Sectional Studies (mesh), Prostate-Specific Antigen (mesh), Antigens, Surface (mesh), Nitriles (mesh), Phenylthiohydantoin (mesh), Neoplasm Staging (mesh), Leuprolide (mesh), Glutamate Carboxypeptidase II (mesh), Benzamides (mesh), 32 Biomedical and clinical sciences (for-2020), 42 Health sciences (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/93x873j3
https://escholarship.org/content/qt93x873j3/qt93x873j3.pdf

The Oncometabolite 2-Hydroxyglutarate Is Upregulated in Post-Prostatectomy PSA Recurrence of Prostate Cancer: A Metabolomic Analysis

Autoren: Hairston, Dontrel W Spencer Sridharan-Weaver, Shamira Gandhi, Abheek et al.

Quelle: Molecules. 30(16)

Schlagwörter: 3404 Medicinal and Biomolecular Chemistry (for-2020), 3405 Organic Chemistry (for-2020), 34 Chemical Sciences (for-2020), Urologic Diseases (rcdc), Prevention (rcdc), Aging (rcdc), Cancer (rcdc), Prostate Cancer (rcdc), 2.1 Biological and endogenous factors (hrcs-rac), Cancer (hrcs-hc), Humans (mesh), Prostatic Neoplasms (mesh), Male (mesh), Prostatectomy (mesh), Prostate-Specific Antigen (mesh), Glutarates (mesh), Middle Aged (mesh), Metabolomics (mesh), Neoplasm Recurrence, Local (mesh), Aged (mesh), Up-Regulation (mesh), Metabolome (mesh), Biomarkers, Tumor (mesh), PSA, localized prostate cancer, phospholipids, triglycerides, tricarboxylic acid cycle, 2-hydroxyglutarate, Humans (mesh), Prostatic Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Glutarates (mesh), Prostate-Specific Antigen (mesh), Prostatectomy (mesh), Up-Regulation (mesh), Aged (mesh), Middle Aged (mesh), Male (mesh), Metabolomics (mesh), Metabolome (mesh), Biomarkers, Tumor (mesh), 2-hydroxyglutarate, PSA, localized prostate cancer, phospholipids, tricarboxylic acid cycle, triglycerides, Humans (mesh), Prostatic Neoplasms (mesh), Male (mesh), Prostatectomy (mesh), Prostate-Specific Antigen (mesh), Glutarates (mesh), Middle Aged (mesh), Metabolomics (mesh), Neoplasm Recurrence, Local (mesh), Aged (mesh), Up-Regulation (mesh), Metabolome (mesh), Biomarkers, Tumor (mesh), 0304 Medicinal and Biomolecular Chemistry (for), 0305 Organic Chemistry (for), 0307 Theoretical and Computational Chemistry (for), Organic Chemistry (science-metrix), 3404 Medicinal and biomolecular chemistry (for-2020), 3405 Organic chemistry (for-2020)

Zugangs-URL: https://escholarship.org/uc/item/8p20h143

Targeting PRMT1 Reduces Cancer Persistence and Tumor Relapse in EGFR- and KRAS-Mutant Lung Cancer

Autoren: Sun, Xiaoxiao Kumbier, Karl Gayathri, Savitha et al.

Quelle: Cancer Research Communications. 5(1)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Cancer (rcdc), Women's Health (rcdc), Genetics (rcdc), Precision Medicine (rcdc), Lung Cancer (rcdc), Lung (rcdc), 5.1 Pharmaceuticals (hrcs-rac), 2.1 Biological and endogenous factors (hrcs-rac), Cancer (hrcs-hc), Protein-Arginine N-Methyltransferases (mesh), Humans (mesh), Lung Neoplasms (mesh), Proto-Oncogene Proteins p21(ras) (mesh), ErbB Receptors (mesh), Mutation (mesh), Neoplasm Recurrence, Local (mesh), Animals (mesh), Mice (mesh), Repressor Proteins (mesh), Cell Line, Tumor (mesh), Xenograft Model Antitumor Assays (mesh), Female (mesh), Cell Line, Tumor (mesh), Animals (mesh), Humans (mesh), Mice (mesh), Lung Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Repressor Proteins (mesh), Xenograft Model Antitumor Assays (mesh), Mutation (mesh), Female (mesh), Proto-Oncogene Proteins p21(ras) (mesh), Protein-Arginine N-Methyltransferases (mesh), ErbB Receptors (mesh), Protein-Arginine N-Methyltransferases (mesh), Humans (mesh), Lung Neoplasms (mesh), Proto-Oncogene Proteins p21(ras) (mesh), ErbB Receptors (mesh), Mutation (mesh), Neoplasm Recurrence, Local (mesh), Animals (mesh), Mice (mesh), Repressor Proteins (mesh), Cell Line, Tumor (mesh), Xenograft Model Antitumor Assays (mesh), Female (mesh)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/2t588353
https://escholarship.org/content/qt2t588353/qt2t588353.pdf

Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancer

Autoren: Jones, Veronica Yin, Hongwei Holly Yuan, Yate-Ching et al.

Quelle: Scientific Reports. 15(1)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Women's Health (rcdc), Genetics (rcdc), Breast Cancer (rcdc), Estrogen (rcdc), Cancer (rcdc), 4.1 Discovery and preclinical testing of markers and technologies (hrcs-rac), 5.1 Pharmaceuticals (hrcs-rac), Cancer (hrcs-hc), 3 Good Health and Well Being (sdg), Humans (mesh), Breast Neoplasms (mesh), Female (mesh), Receptors, Estrogen (mesh), Drug Resistance, Neoplasm (mesh), Middle Aged (mesh), Gene Expression Regulation, Neoplastic (mesh), Antineoplastic Agents, Hormonal (mesh), Aged (mesh), Adult (mesh), Neoplasm Recurrence, Local (mesh), Enhancer of Zeste Homolog 2 Protein (mesh), Biomarkers, Tumor (mesh), Gene Expression Profiling (mesh), Humans (mesh), Breast Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Receptors, Estrogen (mesh), Antineoplastic Agents, Hormonal (mesh), Gene Expression Profiling (mesh), Gene Expression Regulation, Neoplastic (mesh), Drug Resistance, Neoplasm (mesh), Adult (mesh), Aged (mesh), Middle Aged (mesh), Female (mesh), Biomarkers, Tumor (mesh), Enhancer of Zeste Homolog 2 Protein (mesh), Humans (mesh), Breast Neoplasms (mesh), Female (mesh), Receptors, Estrogen (mesh), Drug Resistance, Neoplasm (mesh), Middle Aged (mesh), Gene Expression Regulation, Neoplastic (mesh), Antineoplastic Agents, Hormonal (mesh), Aged (mesh), Adult (mesh), Neoplasm Recurrence, Local (mesh), Enhancer of Zeste Homolog 2 Protein (mesh), Biomarkers, Tumor (mesh), Gene Expression Profiling (mesh)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/21z1s196
https://escholarship.org/content/qt21z1s196/qt21z1s196.pdf

Radio-pathomic estimates of cellular growth kinetics predict survival in recurrent glioblastoma

Autoren: Oshima, Sonoko Yao, Jingwen Bobholz, Samuel et al.

Quelle: CNS Oncology. 13(1)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Rare Diseases (rcdc), Brain Disorders (rcdc), Cancer (rcdc), Cancer (hrcs-hc), Humans (mesh), Glioblastoma (mesh), Brain Neoplasms (mesh), Male (mesh), Female (mesh), Middle Aged (mesh), Neoplasm Recurrence, Local (mesh), Magnetic Resonance Imaging (mesh), Aged (mesh), Adult (mesh), Machine Learning (mesh), Prognosis (mesh), Humans (mesh), Glioblastoma (mesh), Brain Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Magnetic Resonance Imaging (mesh), Prognosis (mesh), Adult (mesh), Aged (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), Machine Learning (mesh), MRI, rad-path, radiopathomic mapping, recurrent glioblastoma, survival, tumor growth rate, Humans (mesh), Glioblastoma (mesh), Brain Neoplasms (mesh), Male (mesh), Female (mesh), Middle Aged (mesh), Neoplasm Recurrence, Local (mesh), Magnetic Resonance Imaging (mesh), Aged (mesh), Adult (mesh), Machine Learning (mesh), Prognosis (mesh), 3211 Oncology and carcinogenesis (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/7155h2z4
https://escholarship.org/content/qt7155h2z4/qt7155h2z4.pdf

Smallest Clinically Meaningful Improvement in Amputation-Related Pain and Brief Pain Inventory Scores as Defined by Patient Reports of Global Improvement After Cryoneurolysis: a Retrospective Analysis of a Randomized, Controlled Clinical Trial

Autoren: Ilfeld, Brian M Smith, Cameron R Turan, Alparslan et al.

Quelle: Anesthesia & Analgesia. 139(6)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Chronic Pain (rcdc), Clinical Trials and Supportive Activities (rcdc), Clinical Research (rcdc), Pain Research (rcdc), Humans (mesh), Male (mesh), Amputation, Surgical (mesh), Female (mesh), Middle Aged (mesh), Phantom Limb (mesh), Pain Measurement (mesh), Retrospective Studies (mesh), Aged (mesh), Treatment Outcome (mesh), Nerve Block (mesh), Cryosurgery (mesh), Adult (mesh), Patient Reported Outcome Measures (mesh), Ultrasonography, Interventional (mesh), Anesthetics, Local (mesh), Femoral Nerve (mesh), PAINfRE Investigators, Femoral Nerve (mesh), Humans (mesh), Phantom Limb (mesh), Anesthetics, Local (mesh), Ultrasonography, Interventional (mesh), Pain Measurement (mesh), Treatment Outcome (mesh), Nerve Block (mesh), Cryosurgery (mesh), Retrospective Studies (mesh), Adult (mesh), Aged (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), Patient Reported Outcome Measures (mesh), Amputation, Surgical (mesh), Humans (mesh), Male (mesh), Amputation, Surgical (mesh), Female (mesh), Middle Aged (mesh), Phantom Limb (mesh), Pain Measurement (mesh), Retrospective Studies (mesh), Aged (mesh), Treatment Outcome (mesh), Nerve Block (mesh), Cryosurgery (mesh), Adult (mesh), Patient Reported Outcome Measures (mesh), Ultrasonography, Interventional (mesh), Anesthetics, Local (mesh), Femoral Nerve (mesh), 1103 Clinical Sciences (for), 1109 Neurosciences (for), Anesthesiology (science-metrix), 3202 Clinical sciences (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/7071x1j1
https://escholarship.org/content/qt7071x1j1/qt7071x1j1.pdf

Activation of the Mevalonate Pathway in Response to Anti-cancer Treatments Drives Glioblastoma Recurrences Through Activation of Rac-1

Autoren: He, Ling Ioannidis, Angeliki Hoffman, Carter J et al.

Quelle: Cancer Research Communications. 4(6)

Schlagwörter: 31 Biological Sciences (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Stem Cell Research (rcdc), Brain Cancer (rcdc), Stem Cell Research - Nonembryonic - Non-Human (rcdc), Cancer (rcdc), Rare Diseases (rcdc), Brain Disorders (rcdc), Stem Cell Research - Nonembryonic - Human (rcdc), Orphan Drug (rcdc), Neurosciences (rcdc), 6.1 Pharmaceuticals (hrcs-rac), 5.1 Pharmaceuticals (hrcs-rac), 2.1 Biological and endogenous factors (hrcs-rac), Cancer (hrcs-hc), Glioblastoma (mesh), Mevalonic Acid (mesh), Humans (mesh), Animals (mesh), rac1 GTP-Binding Protein (mesh), Mice (mesh), Brain Neoplasms (mesh), Cell Line, Tumor (mesh), Temozolomide (mesh), Hydroxymethylglutaryl-CoA Reductase Inhibitors (mesh), Neoplasm Recurrence, Local (mesh), Xenograft Model Antitumor Assays (mesh), Neoplastic Stem Cells (mesh), Signal Transduction (mesh), Dopamine Antagonists (mesh), Cell Line, Tumor (mesh), Animals (mesh), Humans (mesh), Mice (mesh), Glioblastoma (mesh), Brain Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Mevalonic Acid (mesh), rac1 GTP-Binding Protein (mesh), Dopamine Antagonists (mesh), Hydroxymethylglutaryl-CoA Reductase Inhibitors (mesh), Xenograft Model Antitumor Assays (mesh), Signal Transduction (mesh), Neoplastic Stem Cells (mesh), Temozolomide (mesh), Glioblastoma (mesh), Mevalonic Acid (mesh), Humans (mesh), Animals (mesh), rac1 GTP-Binding Protein (mesh), Mice (mesh), Brain Neoplasms (mesh), Cell Line, Tumor (mesh), Temozolomide (mesh), Hydroxymethylglutaryl-CoA Reductase Inhibitors (mesh), Neoplasm Recurrence, Local (mesh), Xenograft Model Antitumor Assays (mesh), Neoplastic Stem Cells (mesh), Signal Transduction (mesh), Dopamine Antagonists (mesh)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/0j5645tk
https://escholarship.org/content/qt0j5645tk/qt0j5645tk.pdf

Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy

Autoren: Magbanua, Mark Jesus M Ahmed, Ziad Sayaman, Rosalyn W et al.

Quelle: Clinical Cancer Research. 30(11)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Human Genome (rcdc), Precision Medicine (rcdc), Cancer Genomics (rcdc), Genetics (rcdc), Breast Cancer (rcdc), Women's Health (rcdc), Cancer (rcdc), 4.2 Evaluation of markers and technologies (hrcs-rac), Cancer (hrcs-hc), 3 Good Health and Well Being (sdg), Adult (mesh), Aged (mesh), Female (mesh), Humans (mesh), Middle Aged (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), Biomarkers, Tumor (mesh), Breast Neoplasms (mesh), Cell-Free Nucleic Acids (mesh), Circulating Tumor DNA (mesh), Neoadjuvant Therapy (mesh), Neoplasm Recurrence, Local (mesh), Prognosis (mesh), Receptor, ErbB-2 (mesh), Treatment Outcome (mesh), Triple Negative Breast Neoplasms (mesh), Humans (mesh), Breast Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Receptor, erbB-2 (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), Prognosis (mesh), Treatment Outcome (mesh), Neoadjuvant Therapy (mesh), Adult (mesh), Aged (mesh), Middle Aged (mesh), Female (mesh), Triple Negative Breast Neoplasms (mesh), Biomarkers, Tumor (mesh), Cell-Free Nucleic Acids (mesh), Circulating Tumor DNA (mesh), Adult (mesh), Aged (mesh), Female (mesh), Humans (mesh), Middle Aged (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), Biomarkers, Tumor (mesh), Breast Neoplasms (mesh), Cell-Free Nucleic Acids (mesh), Circulating Tumor DNA (mesh), Neoadjuvant Therapy (mesh), Neoplasm Recurrence, Local (mesh), Prognosis (mesh), Receptor, ErbB-2 (mesh), Treatment Outcome (mesh), Triple Negative Breast Neoplasms (mesh), 1112 Oncology and Carcinogenesis (for), Oncology & Carcinogenesis (science-metrix), 3202 Clinical sciences (for-2020), 3211 Oncology and carcinogenesis (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/1gt531f2
https://escholarship.org/content/qt1gt531f2/qt1gt531f2.pdf

Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution

Autoren: Lucas, Calixto-Hope G Mirchia, Kanish Seo, Kyounghee et al.

Quelle: Nature Genetics. 56(6)

Schlagwörter: 30 Agricultural, Veterinary and Food Sciences (for-2020), 31 Biological Sciences (for-2020), 3102 Bioinformatics and Computational Biology (for-2020), 3105 Genetics (for-2020), 3001 Agricultural Biotechnology (for-2020), Rare Diseases (rcdc), Human Genome (rcdc), Cancer (rcdc), Genetics (rcdc), Brain Cancer (rcdc), Biotechnology (rcdc), Cancer Genomics (rcdc), Precision Medicine (rcdc), Brain Disorders (rcdc), Cancer (hrcs-hc), 3 Good Health and Well Being (sdg), Meningioma (mesh), Humans (mesh), Meningeal Neoplasms (mesh), Genetic Heterogeneity (mesh), DNA Copy Number Variations (mesh), Gene Expression Regulation, Neoplastic (mesh), Genomics (mesh), Single-Cell Analysis (mesh), Cell Proliferation (mesh), Neoplasm Recurrence, Local (mesh), Signal Transduction (mesh), Cell Line, Tumor (mesh), Transcriptome (mesh), Cell Line, Tumor (mesh), Humans (mesh), Meningioma (mesh), Meningeal Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Genomics (mesh), Signal Transduction (mesh), Cell Proliferation (mesh), Gene Expression Regulation, Neoplastic (mesh), Genetic Heterogeneity (mesh), DNA Copy Number Variations (mesh), Single-Cell Analysis (mesh), Transcriptome (mesh), Meningioma (mesh), Humans (mesh), Meningeal Neoplasms (mesh), Genetic Heterogeneity (mesh), DNA Copy Number Variations (mesh), Gene Expression Regulation, Neoplastic (mesh), Genomics (mesh), Single-Cell Analysis (mesh), Cell Proliferation (mesh), Neoplasm Recurrence, Local (mesh), Signal Transduction (mesh), Cell Line, Tumor (mesh), Transcriptome (mesh), 06 Biological Sciences (for), 11 Medical and Health Sciences (for), Developmental Biology (science-metrix), 3001 Agricultural biotechnology (for-2020), 3102 Bioinformatics and computational biology (for-2020), 3105 Genetics (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/3sx7d9gv
https://escholarship.org/content/qt3sx7d9gv/qt3sx7d9gv.pdf

Adoptive cellular therapy after hematopoietic stem cell transplantation

Autoren: Vittayawacharin, Pongthep Kongtim, Piyanuch Chu, Yaya et al.

Quelle: American Journal of Hematology. 99(5)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), 3204 Immunology (for-2020), Transplantation (rcdc), Immunization (rcdc), Stem Cell Research (rcdc), Hematology (rcdc), Immunotherapy (rcdc), Rare Diseases (rcdc), Cancer (rcdc), Regenerative Medicine (rcdc), Vaccine Related (rcdc), Stem Cell Research - Nonembryonic - Human (rcdc), 5.2 Cellular and gene therapies (hrcs-rac), 6.2 Cellular and gene therapies (hrcs-rac), Cancer (hrcs-hc), Humans (mesh), Neoplasm Recurrence, Local (mesh), T-Lymphocytes (mesh), Killer Cells, Natural (mesh), Hematopoietic Stem Cell Transplantation (mesh), Recurrence (mesh), Immunotherapy, Adoptive (mesh), Antigens, CD19 (mesh), Killer Cells, Natural (mesh), T-Lymphocytes (mesh), Humans (mesh), Neoplasm Recurrence, Local (mesh), Recurrence (mesh), Antigens, CD19 (mesh), Immunotherapy, Adoptive (mesh), Hematopoietic Stem Cell Transplantation (mesh), Humans (mesh), Neoplasm Recurrence, Local (mesh), T-Lymphocytes (mesh), Killer Cells, Natural (mesh), Hematopoietic Stem Cell Transplantation (mesh), Recurrence (mesh), Immunotherapy, Adoptive (mesh), Antigens, CD19 (mesh), 1102 Cardiorespiratory Medicine and Haematology (for), Immunology (science-metrix), 3201 Cardiovascular medicine and haematology (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/5nk518ft
https://escholarship.org/content/qt5nk518ft/qt5nk518ft.pdf

Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial

Autoren: Brown, Christine E Hibbard, Jonathan C Alizadeh, Darya et al.

Quelle: Nature Medicine. 30(4)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), 3204 Immunology (for-2020), Clinical Research (rcdc), Clinical Trials and Supportive Activities (rcdc), Brain Disorders (rcdc), Health Disparities (rcdc), Gene Therapy (rcdc), Immunotherapy (rcdc), Minority Health (rcdc), Rare Diseases (rcdc), Biotechnology (rcdc), Genetics (rcdc), Cancer (rcdc), Orphan Drug (rcdc), Neurosciences (rcdc), Brain Cancer (rcdc), 6.1 Pharmaceuticals (hrcs-rac), 6.2 Cellular and gene therapies (hrcs-rac), Cancer (hrcs-hc), Humans (mesh), Receptors, Chimeric Antigen (mesh), Neoplasm Recurrence, Local (mesh), Glioma (mesh), T-Lymphocytes (mesh), Glioblastoma (mesh), Immunotherapy, Adoptive (mesh), T-Lymphocytes (mesh), Humans (mesh), Glioma (mesh), Glioblastoma (mesh), Neoplasm Recurrence, Local (mesh), Immunotherapy, Adoptive (mesh), Receptors, Chimeric Antigen (mesh), Humans (mesh), Receptors, Chimeric Antigen (mesh), Neoplasm Recurrence, Local (mesh), Glioma (mesh), T-Lymphocytes (mesh), Glioblastoma (mesh), Immunotherapy, Adoptive (mesh), 11 Medical and Health Sciences (for), Immunology (science-metrix), 32 Biomedical and clinical sciences (for-2020), 42 Health sciences (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/9r58c262
https://escholarship.org/content/qt9r58c262/qt9r58c262.pdf

Intravenous lidocaine as an adjuvant to propofol sedation for elderly patients undergoing same-visit bidirectional endoscopy: protocol for a multicenter randomized controlled trial

Autoren: Ying Liu Nan Song Jing-tao Zhang et al.

Quelle: Annals of Medicine, vol 57, iss 1

Schlagwörter: hypotension, Conscious Sedation (mesh), Lidocaine (mesh), Clinical Trials and Supportive Activities (rcdc), Endoscopy (mesh), Propofol (mesh), Hypnotics and Sedatives (mesh), 11 Medical and Health Sciences (for), China (mesh), Aging (rcdc), Clinical Research (rcdc), Sufentanil (mesh), 42 Health sciences (for-2020), 80 and over (mesh), Cardiovascular System & Hematology (science-metrix), 32 Biomedical and Clinical Sciences (for-2020), Double-Blind Method (mesh), Male (mesh), 3202 Clinical Sciences (for-2020), Anesthetics, Aged, Humans (mesh), 6.1 Pharmaceuticals (hrcs-rac), Patient Safety (rcdc), propofol, Aged (mesh), Lidocaine, desaturation, Multicenter Studies as Topic (mesh), Randomized Controlled Trials as Topic (mesh), bidirectional endoscopy, 32 Biomedical and clinical sciences (for-2020), Female (mesh), Intravenous (mesh), Administration, Local (mesh)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/18k1r5q6
https://escholarship.org/content/qt18k1r5q6/qt18k1r5q6.pdf

NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence

Autoren: Mendiburu‐Eliçabe, Marina García‐Sancha, Natalia Corchado‐Cobos, Roberto et al.

Quelle: Clinical and Translational Medicine. 14(2)

Schlagwörter: 4205 Nursing (for-2020), 42 Health Sciences (for-2020), Cancer (rcdc), Genetics (rcdc), Precision Medicine (rcdc), Women's Health (rcdc), Breast Cancer (rcdc), 2.1 Biological and endogenous factors (hrcs-rac), Cancer (hrcs-hc), Humans (mesh), Mice (mesh), Animals (mesh), Female (mesh), Breast Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Gene Expression Profiling (mesh), Prognosis (mesh), Mice, Transgenic (mesh), Nuclear Proteins (mesh), Cell Cycle Proteins (mesh), breast cancer, genetic signature, LASSO, luminal A subtype, NCAPH, prognosis, relapse-free survival, breast cancer, genetic signature, LASSO, luminal A subtype, NCAPH, prognosis, relapse-free survival, Animals (mesh), Mice, Transgenic (mesh), Humans (mesh), Mice (mesh), Breast Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Cell Cycle Proteins (mesh), Nuclear Proteins (mesh), Prognosis (mesh), Gene Expression Profiling (mesh), Female (mesh), LASSO, NCAPH, breast cancer, genetic signature, luminal A subtype, prognosis, relapse-free survival, Humans (mesh), Mice (mesh), Animals (mesh), Female (mesh), Breast Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Gene Expression Profiling (mesh), Prognosis (mesh), Mice, Transgenic (mesh), Nuclear Proteins (mesh), Cell Cycle Proteins (mesh), 1110 Nursing (for), 4205 Nursing (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/29d362ks
https://escholarship.org/content/qt29d362ks/qt29d362ks.pdf

Metabolomic characterization of human glioblastomas and patient plasma: a pilot study

Autoren: Liu, Yin Allison Aboud, Orwa Dahabiyeh, Lina A et al.

Quelle: F1000Research. 13

Schlagwörter: 3205 Medical Biochemistry and Metabolomics (for-2020), 3401 Analytical Chemistry (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 34 Chemical Sciences (for-2020), Cancer (rcdc), Health Disparities (rcdc), Brain Disorders (rcdc), Neurosciences (rcdc), Clinical Research (rcdc), Rare Diseases (rcdc), Precision Medicine (rcdc), Minority Health (rcdc), Brain Cancer (rcdc), 4.1 Discovery and preclinical testing of markers and technologies (hrcs-rac), Cancer (hrcs-hc), 3205 Medical Biochemistry and Metabolomics (for-2020), 3401 Analytical Chemistry (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 34 Chemical Sciences (for-2020), Rare Diseases (rcdc), Clinical Research (rcdc), Cancer (rcdc), Brain Cancer (rcdc), Precision Medicine (rcdc), Brain Disorders (rcdc), Health Disparities (rcdc), Minority Health (rcdc), Neurosciences (rcdc), 4.1 Discovery and preclinical testing of markers and technologies (hrcs-rac), Cancer (hrcs-hc), Humans (mesh), Glioblastoma (mesh), Pilot Projects (mesh), Metabolomics (mesh), Brain Neoplasms (mesh), Male (mesh), Female (mesh), Middle Aged (mesh), Aged (mesh), Metabolome (mesh), Adult (mesh), Neoplasm Recurrence, Local (mesh), Humans (mesh), Glioblastoma (mesh), Brain Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Pilot Projects (mesh), Adult (mesh), Aged (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), Metabolomics (mesh), Metabolome (mesh), biomarker, feasibility, glioblastoma, pilot, untargeted metabolomics, Humans (mesh), Glioblastoma (mesh), Pilot Projects (mesh), Metabolomics (mesh), Brain Neoplasms (mesh), Male (mesh), Female (mesh), Middle Aged (mesh), Aged (mesh), Metabolome (mesh), Adult (mesh), Neoplasm Recurrence, Local (mesh), 06 Biological Sciences (for), 11 Medical and Health Sciences (for)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/34h261zd
https://escholarship.org/content/qt34h261zd/qt34h261zd.pdf

RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults

Autoren: Wen, Patrick Y van den Bent, Martin Youssef, Gilbert et al.

Quelle: Journal of Clinical Oncology. 41(33)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Brain Disorders (rcdc), Cancer (rcdc), Brain Cancer (rcdc), Rare Diseases (rcdc), Neurosciences (rcdc), Orphan Drug (rcdc), Biomedical Imaging (rcdc), 4.2 Evaluation of markers and technologies (hrcs-rac), Cancer (hrcs-hc), Humans (mesh), Adult (mesh), Brain Neoplasms (mesh), Reproducibility of Results (mesh), Neoplasm Recurrence, Local (mesh), Glioma (mesh), Magnetic Resonance Imaging (mesh), Humans (mesh), Glioma (mesh), Brain Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Magnetic Resonance Imaging (mesh), Reproducibility of Results (mesh), Adult (mesh), Humans (mesh), Adult (mesh), Brain Neoplasms (mesh), Reproducibility of Results (mesh), Neoplasm Recurrence, Local (mesh), Glioma (mesh), Magnetic Resonance Imaging (mesh), 1103 Clinical Sciences (for), 1112 Oncology and Carcinogenesis (for), Oncology & Carcinogenesis (science-metrix), 3211 Oncology and carcinogenesis (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/1zv2z6bg
https://escholarship.org/content/qt1zv2z6bg/qt1zv2z6bg.pdf

Depth of Radiographic Response and Time to Tumor Regrowth Predicts Overall Survival Following Anti-VEGF Therapy in Recurrent Glioblastoma.

Autoren: Ellingson, Benjamin M Hagiwara, Akifumi Morris, Connor J et al.

Quelle: Clinical Cancer Research. 29(20)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Rare Diseases (rcdc), Brain Disorders (rcdc), Brain Cancer (rcdc), Biomedical Imaging (rcdc), Neurosciences (rcdc), Cancer (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Cancer (hrcs-hc), Humans (mesh), Glioblastoma (mesh), Bevacizumab (mesh), Angiogenesis Inhibitors (mesh), Brain Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Irinotecan (mesh), Magnetic Resonance Imaging (mesh), Humans (mesh), Glioblastoma (mesh), Brain Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Angiogenesis Inhibitors (mesh), Magnetic Resonance Imaging (mesh), Bevacizumab (mesh), Irinotecan (mesh), Humans (mesh), Glioblastoma (mesh), Bevacizumab (mesh), Angiogenesis Inhibitors (mesh), Brain Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Irinotecan (mesh), Magnetic Resonance Imaging (mesh), 1112 Oncology and Carcinogenesis (for), Oncology & Carcinogenesis (science-metrix), 3202 Clinical sciences (for-2020), 3211 Oncology and carcinogenesis (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/10n0m73x
https://escholarship.org/content/qt10n0m73x/qt10n0m73x.pdf